「th」の検索結果
184件：171～175件目を表示
-
Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval for a partial change in the marketing authorization of “Aibeta® Combin...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
学会发表 | 研究与开发 | 千寿制药株式会社
Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：...
https://www.senju.co.jp/chinese/rd/society/ -
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：...
https://www.senju.co.jp/rd/society/ -
学会发表 | 研究与开发 | 千寿制药株式会社
Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：...
http://www.senju.co.jp/chinese/rd/society/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：...
https://www.senju.co.jp/english/rd/society/